Last update 08 May 2025

Hydrochlorothiazide/Moexipril Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Uniretic
Target
ACE x NCC
Action
inhibitors
Mechanism
ACE inhibitors(Angiotensin-converting enzyme inhibitors), NCC inhibitors(Thiazide-sensitive sodium-chloride cotransporter inhibitors)
Therapeutic Areas
Cardiovascular Diseases
Active Indication-
Inactive Indication
Hypertension
Originator Organization
UCB SAUCB SA
Active Organization-
Inactive Organization
UCB, Inc.UCB, Inc.
License Organization-
Drug Highest PhaseWithdrawn
First Approval Date
United States (27 Jun 1997),
Hypertension
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC7H8ClN3O4S2
InChIKeyJZUFKLXOESDKRF-UHFFFAOYSA-N
CAS Registry58-93-5
View All Structures (2)

Related

2
Clinical Trials associated with Hydrochlorothiazide/Moexipril Hydrochloride
NCT00834067
/ CompletedPhase 1
A Relative Bioavailability Study of Moexipril HCl/Hydrochlorothiazide 15/25 mg Tablets Under Non-Fasting Conditions
NCT00835042
/ CompletedPhase 1
A Relative Bioavailability Study of Moexipril HCL/Hydrochlorothiazide 15/25 mg Tablets Under Fasting Conditions
100 Clinical Results associated with Hydrochlorothiazide/Moexipril Hydrochloride
Login to view more data
100 Translational Medicine associated with Hydrochlorothiazide/Moexipril Hydrochloride
Login to view more data
100 Patents (Medical) associated with Hydrochlorothiazide/Moexipril Hydrochloride
Login to view more data
100 Deals associated with Hydrochlorothiazide/Moexipril Hydrochloride
Login to view more data

External Link

KEGGWikiATCDrug Bank
--
C09BA13
-

R&D Status

Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT00834067 (CTgov)
Phase 1
-
60
Moexipril HCl+HCTZ
(Test (Moexipril HCl/HCTZ))
xoosopejit(xhyiipangh) = cdilngjgqs jgdxybqolz (fuwmsnspoi, cfacfhkozb - uuftkfsitg)
View more
-
18 Aug 2009
(Reference (Uniretic®))
xoosopejit(xhyiipangh) = kyrfutigtq jgdxybqolz (fuwmsnspoi, cvewrbeplc - waebqafyiq)
View more
NCT00835042 (CTgov)
Phase 1
-
60
Moexipril HCl+HCTZ
(Test (Moexipril HCl/HCTZ))
drtghveyfk(iaugazlcwo) = plymdaxsdu fxxytlyayo (rryubianpm, rgmdpagmht - cnzdeihbvq)
View more
-
18 Aug 2009
(Reference (Uniretic®))
drtghveyfk(iaugazlcwo) = mmqacqbwgx fxxytlyayo (rryubianpm, cuygjgzgwc - wshxibykbl)
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free